Iceland· IS-EU/1/12/812/001-004
Bexsero
A meningokokkus b, multikomponenten-impfstoff product containing recombinant neisseria meningitidis serogroup b nada fusion protein,recombinant neisseria meningitidis serogroup b nhba fusion protein,recombinant neisseria meningitidis serogroup b fhbp fusion protein,outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254), registered in Iceland by GlaxoSmithKline Vaccines S.r.l.. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Meningokokkus b, multikomponenten-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC J07AH09 (meningokokkus b, multikomponenten-impfstoff), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Meningokokkus b, multikomponenten-impfstoff · ATC J07AH09
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Recombinant Neisseria meningitidis serogroup B NadA fusion protein,Recombinant Neisseria meningitidis serogroup B NHBA fusion protein,Recombinant Neisseria meningitidis serogroup B fHBP fusion protein,Outer membrane vesicles from neisseria meningitidis group B (strain NZ 98/254)
- Manufacturer
- GlaxoSmithKline Vaccines S.r.l.
- Country
- Iceland (IS)
- ATC code
- J07AH09
- ATC class
- Meningokokkus B, Multikomponenten-Impfstoff
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean9696020,5 ml x1 sprISK 29610
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH09
Meningokokkus b, multikomponenten-impfstoff, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32870749-398f-4be9-9e60-5d9ddcd11f0c GET /v1/drugs/32870749-398f-4be9-9e60-5d9ddcd11f0c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, dreifa",
"source": "lyfjastofnun",
"atc_raw": "J07AH09",
"marketed": false,
"strength": "0,5 ml",
"ma_number": "EU/1/12/812/001-004",
"substance": "Recombinant Neisseria meningitidis serogroup B NadA fusion protein,Recombinant Neisseria meningitidis serogroup B NHBA fusion protein,Recombinant Neisseria meningitidis serogroup B fHBP fusion protein,Outer membrane vesicles from neisseria meningitidis group B (strain NZ 98/254)",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "41292"
}See everything about meningokokkus b, multikomponenten-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.